Bovine Tuberculosis (bTB) remains one of the most persistent and complex challenges in veterinary medicine. Primarily caused by Mycobacterium bovis, this chronic infectious disease is characterized by the formation of granulomatous lesions, known as tubercles, in various organs. While its name suggests a bovine-specific pathogen, M. bovis possesses an exceptionally broad host range, infecting wildlife, domestic pets, and humans, making it a cornerstone of One Health surveillance.
Mycobacterium bovis belongs to the M. tuberculosis complex (MTBC). It is a slow-growing, aerobic, Gram-positive, acid-fast bacillus. Its most striking feature is a cell wall exceptionally rich in mycolic acids and lipids, which confers resistance to environmental desiccation, many disinfectants, and the host's innate immune system.
The pathogenesis is fundamentally a battle of attrition between the bacteria and the host’s cellular immunity. Following inhalation (the most common route in cattle) or ingestion, the bacilli are engulfed by alveolar macrophages. Instead of being destroyed, the bacteria inhibit phagosome-lysosome fusion. This triggers a localized, chronic inflammatory response, resulting in the "tubercle": a central zone of caseous necrosis (sometimes calcified), surrounded by epithelioid cells, multinucleated giant cells (Langhans cells), and a peripheral fibrous capsule.
Bovine TB is notoriously insidious. In many developed nations with active surveillance, clinical cases are rare because animals are identified and culled in the subclinical phase. However, in advanced or untreated cases, the "wasting disease" aspect becomes evident:
Diagnosis is complicated by the bacteria's slow growth (culturing can take up to 8 weeks) and the lack of an early-stage antibody response. Consequently, we rely on detecting Cell-Mediated Immunity (CMI).
In most jurisdictions, bTB is a statutory disease. Treatment of livestock is strictly prohibited due to the risk of creating antibiotic resistance, the long duration required for therapy, and the high risk of relapse. Control strategies focus on:
Human tuberculosis caused by M. bovis is clinically indistinguishable from M. tuberculosis. Before the widespread adoption of pasteurization, M. bovis was a leading cause of extrapulmonary tuberculosis in children (scrofula). Today, human cases primarily occur in veterinarians, abattoir workers, and those consuming "raw" dairy products.
As a veterinarian, your role in bTB management is largely one of vigilance and regulatory precision. Accurate administration and reading of the tuberculin test are the first line of defense. Furthermore, educating clients on biosecurity—specifically preventing cattle contact with wildlife and maintaining "closed" herds—remains the most effective tool in preventing the introduction of this resilient pathogen into a farming operation.
Home